STERIS’ (TSE:STE – Free Report) – Equities research analysts at Cormark dropped their FY2025 earnings estimates for shares of STERIS’ in a report issued on Tuesday, November 5th. Cormark analyst B. Watson now expects that the company will post earnings per share of $0.94 for the year, down from their prior estimate of $1.02.
STERIS’ (TSE:STE – Get Free Report) last released its quarterly earnings results on Tuesday, August 6th. The company reported C$0.14 earnings per share for the quarter, beating analysts’ consensus estimates of C$0.12 by C$0.02. The business had revenue of C$231.38 million for the quarter, compared to analyst estimates of C$226.20 million.
STERIS’ Stock Performance
STERIS’ Company Profile
STERIS’s MISSION IS TO HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life science product and service solutions around the globe by providing innovative healthcare and life science product and service solutions around the globe.
Featured Articles
- Five stocks we like better than STERIS’
- How to Invest in Small Cap Stocks
- What a Trump Win Looks Like for the Market Now and Into 2025
- What is Forex and How Does it Work?
- Russell 2000 Surge Post-Election: How to Play the Small-Cap Pop
- What is a Dividend King?
- Macro Headwinds Send Microchip Technology Stock to the Buy Zone
Receive News & Ratings for STERIS’ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS’ and related companies with MarketBeat.com's FREE daily email newsletter.
